RT Journal Article
SR Electronic
T1 Adaptive combination of interventions required to reach population immunity due to stochastic community dynamics and limited vaccination
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.12.16.20248301
DO 10.1101/2020.12.16.20248301
A1 Björn Goldenbogen
A1 Stephan O Adler
A1 Oliver Bodeit
A1 Judith AH Wodke
A1 Ximena Escalera-Fanjul
A1 Aviv Korman
A1 Maria Krantz
A1 Lasse Bonn
A1 Rafael Morán-Torres
A1 Johanna EL Haffner
A1 Maxim Karnetzki
A1 Ivo Maintz
A1 Lisa Mallis
A1 Hannah Prawitz
A1 Patrick S Segelitz
A1 Martin Seeger
A1 Rune Linding
A1 Edda Klipp
YR 2021
UL http://medrxiv.org/content/early/2021/07/16/2020.12.16.20248301.abstract
AB Reaching population immunity against COVID-19 is proving difficult even in countries with high vaccination levels. We demonstrate that this in part is due to heterogeneity and stochasticity resulting from community-specific human-human interaction and infection networks. We address this challenge by community-specific simulation of adaptive strategies. Analyzing the predicted effect of vaccination into an ongoing COVID-19 outbreak, we find that adaptive combinations of targeted vaccination and non-pharmaceutical interventions (NPIs) are required to reach population immunity. Importantly, the threshold for population immunity is not a unique number but strategy and community dependent. Furthermore, the dynamics of COVID-19 outbreaks is highly community-specific: in some communities vaccinating highly interactive people diminishes the risk for an infection wave, while vaccinating the elderly reduces fatalities when vaccinations are low due to supply or hesitancy. Similarly, while risk groups should be vaccinated first to minimize fatalities, optimality branching is observed with increasing population immunity. Bimodality emerges as the infection network gains complexity over time, which entails that NPIs generally need to be longer and stricter. Thus, we analyze and quantify the requirement for NPIs dependent on the chosen vaccination strategy. We validate our simulation platform on real-world epidemiological data and demonstrate that it can predict pathways to population immunity for diverse communities world-wide challenged by limited vaccination.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was supported by the Deutsche Forschungsgemeinschaft (DFG: TRR 175, Germany's Excellence Strategy - The Berlin Mathematics Research Center MATHplus (EXC-2046/1, project ID 390685689, subproject EF4-11) and by the German Ministry of Education and Research (BMBF, Liver Systems Medicine (LiSyM) network grant) and by the People Programme (Marie Skłodowska-Curie Actions) of the European Union's Horizon 2020 Programme under REA grant agreement no. 813979 (Secreters). XEF is supported with a postdoctoral grant from CONACYT (CVU 420248). RL is supported by a BMBF GO-Bio initial grant 031B0988.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:No ethical approval requiredAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data used are included in the supplementary material.